Preoperative antiplatelet and statin treatment was not associated with reduced myocardial infarction after high-risk vascular operations in the Vascular Quality Initiative

Medical management with antiplatelet (AP) and statin therapy is recommended for nearly all patients undergoing vascular surgery to reduce cardiovascular events. We assessed the association between preoperative use of AP and statin medications and postoperative in-hospital myocardial infarction (MI) in patients undergoing high-risk open surgery.

Source: Journal of Vascular Surgery - September 22, 2015 Category: Surgery Authors: Randall R. De Martino, Adam W. Beck, Andrew W. Hoel, John W. Hallett, Shipra Arya, Gilbert R. Upchurch, Jack L. Cronenwett, Philip P. Goodney, Vascular Quality Initiative Tags: Clinical Paper Source Type: research